Functional and immunological characterization of a duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting

Infection and Immunity

Volumn 77, Issue 9, 2009, Pages 3857-3863

  Mayor, Alfredo ^a,b,c   Rovira Vallbona, Eduard ^a   Srivastava, Anand ^b   Sharma, Surya K ^d   Pati, Sudhanshu S ^e   Puyol, Laura ^a   Quinto, Llorenç ^a   Bassat, Quique ^a,c   Machevo, Sonia ^c   Mandomando, Inacio ^c   Chauhan, Virander S ^b   Alonso, Pedro L ^a,c   Chitnis, Chetan E ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c Ministérioda Saúde   (Mozambique)

^d NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^e ISPAT GENERAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; DUFFY BINDING PROTEIN; ERYTHROCYTE MEMBRANE PROTEIN 1; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; ESCHERICHIA COLI; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MOZAMBIQUE; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; ROSETTE FORMATION; SCHOOL CHILD; SEROPREVALENCE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; PLASMODIUM FALCIPARUM; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; PROTOZOAN PROTEINS; RECEPTORS, CELL SURFACE; ROSETTE FORMATION;

EID: 69049084603     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00049-09     Document Type: Article

References (36)

1. Alonso, P. L., J. Sacarlal, J. J. Aponte, A. Leach, E. Macete, J. Milman, I. Mandomando, B. Spiessens, C. Guinovart, M. Espasa, Q. Bassat, P. Aide, O. Ofori-Anyinam, M. M. Navia, S. Corachan, M. Ceuppens, M. C. Dubois, M. A. Demoitie, F. Dubovsky, C. Menendez, N. Tornieporth, W. R. Ballou, R. Thompson, and J. Cohen. 2004. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364:1411-1420.
2. Baruch, D. I., B. L. Pasloske, H. B. Singh, X. Bi, X. C. Ma, M. Feldman, T. F. Taraschi, and R. J. Howard. 1995. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82:77-87.
3. Bir, N., S. S. Yazdani, M. Avril, C. Layez, J. Gysin, and C. E. Chitnis. 2006. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria. Infect. Immun. 74:5955-5963.
4. Bull, P. C., B. S. Lowe, M. Kortok, C. S. Molyneux, C. I. Newbold, and K. Marsh. 1998. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4:358-360.
5. Carlson, J., H. Helmby, A. V. Hill, D. Brewster, B. M. Greenwood, and M. Wahlgren. 1990. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336:1457-1460.
6. Chattopadhyay, R., A. Sharma, V. K. Srivastava, S. S. Pati, S. K. Sharma, B. S. Das, and C. E. Chitnis. 2003. Plasmodium falciparum infection elicits both variant-specific and cross-reactive antibodies against variant surface antigens. Infect. Immun. 71:597-604.
7. Chen, Q., A. Barragan, V. Fernandez, A. Sundstrom, M. Schlichtherle, A. Sahlen, J. Carlson, S. Datta, and M. Wahlgren. 1998. Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J. Exp. Med. 187:15-23.
8. Chen, Q., F. Pettersson, A. M. Vogt, B. Schmidt, S. Ahuja, P. Liljestrom, and M. Wahlgren. 2004. Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine 22:2701-2712.
9. Cohen, S., G. I. McGregor, and S. Carrington. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192:733-737.
10. Druilhe, P., and J. L. Perignon. 1994. Mechanisms of defense against P. falciparum asexual blood stages in humans. Immunol. Lett. 41:115-120.
11. Flick, K., and Q. Chen. 2004. var genes, PfEMP1 and the human host. Mol. Biochem. Parasitol. 134:3-9.
12. Frank, M., and K. Deitsch. 2006. Activation, silencing and mutually exclusive expression within the var gene family of Plasmodium falciparum. Int. J. Parasitol. 36:975-985.
13. Giha, H. A., T. Staalsoe, D. Dodoo, C. Roper, G. M. Satti, D. E. Arnot, L. Hviid, and T. G. Theander. 2000. Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections. Immunol. Lett. 71:117-126.
14. Guinovart, C., Q. Bassat, B. Sigauque, P. Aide, J. Sacarlal, T. Nhampossa, A. Bardaji, A. Nhacolo, E. Macete, I. Mandomando, J. J. Aponte, C. Menendez, and P. L. Alonso. 2008. Malaria in rural Mozambique. I. Children attending the outpatient clinic. Malar. J. 7:36.
15. Gupta, S., K. Trenholme, R. M. Anderson, and K. P. Day. 1994. Antigenic diversity and the transmission dynamics of Plasmodium falciparum. Science 263:961-963.
16. INDEPTH. 2002. Population and health in developing countries. International Development Research Centre, Ottawa, Canada.
17. Koch, R. 1900. Zweiter bericht über die thatigkeit der malaria expedition. Dtsch. Med. Wochenschr. 26:88-90.
18. Kraemer, S. M., and J. D. Smith. 2006. A family affair: var genes, PfEMP1 binding, and malaria disease. Curr. Opin. Microbiol. 9:374-380.
19. Marsh, K., and R. J. Howard. 1986. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 231:150-153.
20. Mayor, A., N. Bir, R. Sawhney, S. Singh, P. Pattnaik, S. K. Singh, A. Sharma, and C. E. Chitnis. 2005. Receptor-binding residues lie in central regions of Duffy-binding-like domains involved in red cell invasion and cytoadherence by malaria parasites. Blood 105:2557-2563.
21. Miller, L. H., D. I. Baruch, K. Marsh, and O. K. Doumbo. 2002. The pathogenic basis of malaria. Nature 415:673-679.
22. Moll, K., F. Pettersson, A. M. Vogt, C. Jonsson, N. Rasti, S. Ahuja, M. Spangberg, O. Mercereau-Puijalon, D. E. Arnot, M. Wahlgren, and Q. Chen. 2007. Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain. Infect. Immun. 75:211-219.
23. Newbold, C., P. Warn, G. Black, A. Berendt, A. Craig, B. Snow, M. Msobo, N. Peshu, and K. Marsh. 1997. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 57:389-398.
24. Oguariri, R. M., S. Borrmann, M. Q. Klinkert, P. G. Kremsner, and J. F. Kun. 2001. High prevalence of human antibodies to recombinant Duffy binding-like alpha domains of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in semi-immune adults compared to that in nonimmune children. Infect. Immun. 69:7603-7609.
25. Oguariri, R. M., D. Mattei, C. Tena-Tomas, A. C. Uhlemann, P. G. Kremsner, and J. F. Kun. 2003. Recombinant Duffy binding-like-alpha domains of Plasmodium falciparum erythrocyte membrane protein 1 elicit antibodies in rats that recognise conserved epitopes. Parasitol. Res. 90:467-472.
26. Okech, B. A., P. H. Corran, J. Todd, A. Joynson-Hicks, C. Uthaipibull, T. G. Egwang, A. A. Holder, and E. M. Riley. 2004. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect. Immun. 72:1557-1567.
27. Okenu, D. M., E. M. Riley, Q. D. Bickle, P. U. Agomo, A. Barbosa, J. R. Daugherty, D. E. Lanar, and D. J. Conway. 2000. Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect. Immun. 68:5559-5566.
28. Polley, S. D., T. Mwangi, C. H. Kocken, A. W. Thomas, S. Dutta, D. E. Lanar, E. Remarque, A. Ross, T. N. Williams, G. Mwambingu, B. Lowe, D. J. Conway, and K. Marsh. 2004. Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23:718-728.
29. Quelhas, D., L. Puyol, L. Quinto, E. Serra-Casas, T. Nhampossa, E. Macete, P. Aide, A. Mayor, I. Mandomando, S. Sanz, J. J. Aponte, V. S. Chauhan, C. E. Chitnis, P. L. Alonso, C. Menendez, and C. Dobano. 2008. Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique. Clin. Vaccine Immunol. 15:1282-1291.
30. Rowe, A., J. Obeiro, C. I. Newbold, and K. Marsh. 1995. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect. Immun. 63:2323-2326.
31. Rowe, J. A., J. M. Moulds, C. I. Newbold, and L. H. Miller. 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388:292-295.
32. Sharma, S. K., P. K. Tyagi, K. Padhan, A. K. Upadhyay, M. A. Haque, N. Nanda, H. Joshi, S. Biswas, T. Adak, B. S. Das, V. S. Chauhan, C. E. Chitnis, and S. K. Subbarao. 2006. Epidemiology of malaria transmission in forest and plain ecotype villages in Sundargarh District, Orissa, India. Trans. R. Soc. Trop. Med. Hyg. 100:917-925.
33. Singh, S., K. Pandey, R. Chattopadhayay, S. S. Yazdani, A. Lynn, A. Bharadwaj, A. Ranjan, and C. Chitnis. 2001. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax Duffy-binding protein. J. Biol. Chem. 276:17111-17116.
34. Smith, J. D., G. Subramanian, B. Gamain, D. I. Baruch, and L. H. Miller. 2000. Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol. Biochem. Parasitol. 110:293-310.
35. Thomas, A. W., J. F. Trape, C. Rogier, A. Goncalves, V. E. Rosario, and D. L. Narum. 1994. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Am. J. Trop. Med. Hyg. 51:730-740.
36. Treutiger, C. J., I. Hedlund, H. Helmby, J. Carlson, A. Jepson, P. Twumasi, D. Kwiatkowski, B. M. Greenwood, and M. Wahlgren. 1992. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am. J. Trop. Med. Hyg. 46:503-510.